Beijing University of Chinese Medicine, Beijing, 100029, China.
Patent Examination Cooperation (Tianjin) Center of the Patent Office, Tianjin, 300304, China.
Int J Biol Sci. 2020 Jan 14;16(5):752-765. doi: 10.7150/ijbs.40612. eCollection 2020.
Acetaminophen (APAP) refers to a medication used to manage pain and fever symptoms, but it always causes liver injury when overdosed. Zhishi, dried young fruit of , is a famous herbal medicine in Asian countries which is rich in dietary phenolic substances. In this study, the mechanism of Zhishi protected against APAP-induced liver injury was studied more deeply by metabolomic strategy and pharmacological study. The metabolomics results demonstrated that Zhishi can prevent the APAP-induced liver injury model by regulating liver metabolic disorders in glycerophospholipid metabolism, fatty acid biosynthesis and glycerolipid metabolism. Moreover, it is confirmed that Zhishi blocked apoptosis of APAP-induced BRL-3A cell by simultaneously regulating p53 up-regulated apoptosis regulator (PUMA), AMPK-SIRT1 and JNK1 signaling pathways. Our findings indicated that Zhishi exhibited a hepaprotective effect against APAP-induced liver necrosis by inhibiting the PUMA and reversing disorder of liver lipid metabolism which could assist in improving the clinical outcomes of chemical-induced liver injury.
对乙酰氨基酚(APAP)是一种用于缓解疼痛和发热症状的药物,但过量使用总会导致肝损伤。枳实,即 的干燥幼果,是亚洲国家著名的草药,富含膳食酚类物质。在这项研究中,通过代谢组学策略和药理学研究,更深入地研究了枳实预防 APAP 诱导的肝损伤的机制。代谢组学结果表明,枳实可以通过调节甘油磷脂代谢、脂肪酸生物合成和甘油脂代谢中的肝代谢紊乱来预防 APAP 诱导的肝损伤模型。此外,还证实枳实通过同时调节 p53 上调凋亡调节剂(PUMA)、AMPK-SIRT1 和 JNK1 信号通路来阻止 APAP 诱导的 BRL-3A 细胞凋亡。我们的研究结果表明,枳实通过抑制 PUMA 和逆转肝脂质代谢紊乱来发挥对 APAP 诱导的肝坏死的肝保护作用,这可能有助于改善化学性肝损伤的临床结局。